Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumour Response,”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT04142372
What this trial is testing

Tissue Microarray of Hematological Malignancies

Who this might be right for
Hematological Malignancies
Tampere University Hospital 5,000
Testing effectiveness (Phase 2)WithdrawnNCT03065712
What this trial is testing

Test - Retest Reproducibility of 18F Fluoroestradiol (FES) PET

Who this might be right for
Breast Cancer
University of Texas Southwestern Medical Center
Testing effectiveness (Phase 2)WithdrawnNCT00408967
What this trial is testing

Determine if Either of 2 Doses of Study Drug Given With a Low-dose of Cyclophosphamide After a Complete or Partial Response to a Platinum-based Second-line Therapy in Women With Recurrent Ovarian Carcinoma Results in a Longer Time to Progression When Compared to the First Time to Progression.

Who this might be right for
Ovarian Cancer
EMD Serono
Not applicableLooking for participantsNCT05396612
What this trial is testing

Role of the Immune Environment in Response to Therapy in Breast Cancer

Who this might be right for
Breast CancerER Positive Breast CancerHER2-negative Breast Cancer+1 more
Abramson Cancer Center at Penn Medicine 300
Testing effectiveness (Phase 2)Looking for participantsNCT07068763
What this trial is testing

Node-Sparing Short-Course Radiation Combined With Capecitabine and PD-1/CTLA-4 for MSS Early Rectal Cancer

Who this might be right for
Rectal Cancer
Sir Run Run Shaw Hospital 52
Testing effectiveness (Phase 2)Ended earlyNCT01147536
What this trial is testing

Study of Vitespen (HSPPC-96, Oncophage ®) for Immune Response Assessment in Participants With Resectable Renal Cell Carcinoma at Intermediate Risk of Recurrence

Who this might be right for
Renal Cell Carcinoma
Agenus Inc. 12
Not applicableWithdrawnNCT01045044
What this trial is testing

Magnetic Resonance Imaging (MRI) of Tumor Response and Cognitive Impairment in Breast Cancer Patients Undergoing Chemotherapy

Who this might be right for
Breast Cancer
Kettering Health Network
Testing effectiveness (Phase 2)UnknownNCT01566799
What this trial is testing

Metformin Plus Neoadjuvant Chemotherapy in Breast Cancer

Who this might be right for
Locally Advanced Malignant Neoplasm
Instituto Nacional de Cancerologia de Mexico 60
Post-approval studies (Phase 4)Ended earlyNCT03655821
What this trial is testing

Dose Individualization of Pemetrexed - IMPROVE-II

Who this might be right for
Non Small Cell Lung CancerMesothelioma
Radboud University Medical Center 81
Not applicableStudy completedNCT04882371
What this trial is testing

Comparison of MRI With PET / CT in the Evaluation of Response to Neoadjuvant Therapy Based on the Molecular Subtypes of Breast Cancer

Who this might be right for
Breast CancerChemotherapy Effect
Cem Ilgin Erol 88
Testing effectiveness (Phase 2)Active Not RecruitingNCT00335816
What this trial is testing

Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer

Who this might be right for
Colorectal Cancer
Memorial Sloan Kettering Cancer Center 248
Not applicableStudy completedNCT00005104
What this trial is testing

Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome

Who this might be right for
Polycystic Ovary SyndromeHyperinsulinism
National Center for Research Resources (NCRR) 99
Large-scale testing (Phase 3)Study completedNCT01961609
What this trial is testing

Secukinumab in Tumor Necrosis Factor (TNF) - Inadequate Response (IR) Psoriasis Participants.

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 235
Not applicableUnknownNCT05832593
What this trial is testing

Immunohistochemical Expression of Excision Repair Cross Complementation Group 1 (ERCC1) in Laryngeal Squamous Cell Carcinoma and Its Correlation With Response to Radiotherapy.

Who this might be right for
Laryngeal Squamous Cell Carcinoma
Assiut University 52
Large-scale testing (Phase 3)Active Not RecruitingNCT02655016
What this trial is testing

Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

Who this might be right for
Ovarian Neoplasms
Tesaro, Inc. 733
Not applicableStudy completedNCT01244022
What this trial is testing

Cytokine Changes After Colorectal Cancer Resection

Who this might be right for
Colorectal Cancer
University Hospital Dubrava 28
Testing effectiveness (Phase 2)WithdrawnNCT04655183
What this trial is testing

Study of M4344 in Combination With Niraparib

Who this might be right for
Advanced Solid TumorBreast Cancer
EMD Serono Research & Development Institute, Inc.
Not applicableStudy completedNCT05376566
What this trial is testing

Hydrochloric Acid Lock Therapy for Central Line-associated Bloodstream Infections

Who this might be right for
Central Line-associated Bloodstream Infection (CLABSI)
Rigshospitalet, Denmark 212
Testing effectiveness (Phase 2)Study completedNCT00535470
What this trial is testing

An Open Label Study to Evaluate the Safety and Efficacy of Mechlorethamine(MCH) 0.04% Formulation in Mycosis Fungoides

Who this might be right for
Mycosis Fungoides
Yaupon Therapeutics 100
Large-scale testing (Phase 3)Looking for participantsNCT07558083
What this trial is testing

FOLICOLOR TRIAL: Following Therapy Response Through Liquid Biopsy in Metatstatic Colorectal Cancer Patients

Who this might be right for
Advanced Colorectal Cancer
University Hospital, Antwerp 150
Next Page